HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 11 September 2014

Recently published CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  From the ones listed this time, here's a few in our areas of research interest:

Kuthubutheen J, Mittmann N, Amoodi H, et al. The effect of different utility measures on the cost-effectiveness of bilateral cochlear implantation. Laryngoscope. 2014 Aug 28. [Epub ahead of print] PubMed PMID: 25169819.

Závada J, Uher M, Sisol K, et al. A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study. Ann Rheum Dis. 2014 Aug 27. [Epub ahead of print] PubMed PMID: 25165033.

Alberts SR, Yu TM, Behrens RJ, et al. Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer. Pharmacoeconomics. 2014 Aug 26. [Epub ahead of print] PubMed PMID: 25154747.

Brown ST, Grima DG, Sauriol L. Cost-Effectiveness of Insulin Glargine Versus Sitagliptin in Insulin-Naïve Patients With Type 2 Diabetes Mellitus. Clin Ther. 2014 Aug 20. [Epub ahead of print] PubMed PMID: 25151573.